Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 50Breast Neoplasms 39Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Multiple Myeloma 19Neuroblastoma 18Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Follicular 12Sarcoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 10Hodgkin Disease 10Central Nervous System Neoplasms 9Rhabdomyosarcoma 8Medulloblastoma 8Brain Neoplasms 7Wilms Tumor 6Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Inflammatory Breast Neoplasms 5Waldenstrom Macroglobulinemia 4Ovarian Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Malignant mesenchymal tumor 4Ganglioneuroblastoma 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

lorvotuzumab mertansine 1Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Polymerase Chain Reaction 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Gene Rearrangement 1Gene Expression Profiling 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cytogenetic Analysis 1Cyclophosphamide 1Amplified Fragment Length Polymorphism Analysis 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pleuropulmonary blastoma × Cyclophosphamide × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡